ValuationViz

LXEO fund manager activity

Lexeo Therapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2023 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementNew114,322$532,1680.00%Aug 4, 2026

Q4 2025

ManagerActivitySharesValue% of portfolioFiled
Dan Sundheim - D1 Capital PartnersSold out——0.00%Feb 17, 2026

Older quarters